• In late June 2026, ACM Research, Inc. was removed from several Russell value benchmarks and simultaneously added to multiple Russell growth and growth‑defensive indices, including the Russell 3000 Growth, 3000E Growth, 2500 Growth, and 2000 Growth benchmarks.
• This reclassification from value to growth indices highlights how index providers now view ACM Research as more closely aligned with growth-oriented semiconductor equipment peers, which may influence which institutional investors hold the stock.
• We’ll now examine how ACM Research’s shift into Russell growth benchmarks interacts with its existing investment narrative around China exposure and expansion.

Find 44 companies with promising cash flow potential yet trading below their fair value.

ACM Research Investment Narrative Recap

To own ACM Research, you have to believe its China centered wafer fab equipment business can translate into durable global relevance, supported by differentiated cleaning and plating tools and expanding capacity. The Russell shift from value to growth indices mainly affects which funds might own the shares, but it does not materially change the core near term story, where the key catalyst remains execution on AI and advanced packaging demand, and the biggest risk remains policy and demand concentration tied to China.

The most relevant recent announcement alongside the index changes is ACM’s follow on equity offering of about US$150.0 million in May 2026. That capital raise sits next to its large China and U.S. capacity investments and ongoing high R&D spend, which are central to the bullish catalysts around product breadth and global expansion, but also amplify the risk that slower international adoption or tighter export controls could leave the enlarged footprint underutilized.

Yet behind the growth label, investors still need to be aware of how exposed ACM remains to shifting U.S. China policy and concentrated China demand...

ACM Research's narrative projects $2.0 billion revenue and $293.7 million earnings by 2029.

Uncover how ACM Research's forecasts yield a $102.14 fair value, a 4% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already assuming revenue could reach about US$1.5 billion and earnings near US$193 million, yet if shipment delays, parts shortages and China reliance persist or worsen, their upbeat narrative on ACM’s growth story and the implications of its new growth index status could look very different from what you believe today.

Explore 4 other fair value estimates on ACM Research - why the stock might be worth 41% less than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your ACM Research research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
• Our free ACM Research research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate ACM Research's overall financial health at a glance.

Interested In Other Possibilities?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.